Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivonescimab in advanced hepatocellular carcinoma
NCT07917481Phase 2Not yet recruiting
- Sponsor
- MEDSIR
- Start
- Mar 2027
- Primary completion
- Jun 2029
01
Overview
A Phase 2 trial of ivonescimab in hepatocellular carcinoma (HCC), sponsored by MEDSIR. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
ivonescimab
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT07917481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07917481.